Savara Inc Prepaid Insurance
Savara Inc (SVRA) had Prepaid Insurance of $294.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:PrepaidInsurance · last filed 2026-08-11
- 2026-06-30: Prepaid Insurance $294.00K.
- 2026-03-31: Prepaid Insurance $186.00K.
- 2025-12-31: Prepaid Insurance $215.00K.
- 2025-09-30: Prepaid Insurance $168.00K.
| Period end | Prepaid Insurance |
|---|---|
| 2026-06-30 | $294.00K 10-Q · filed 2026-08-11 |
| 2026-03-31 | $186.00K 10-Q · filed 2026-05-12 |
| 2025-12-31 | $215.00K 10-Q · filed 2026-08-11 |
| 2025-09-30 | $168.00K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $197.00K 10-Q · filed 2025-08-13 |
| 2025-03-31 | $146.00K 10-Q · filed 2025-05-13 |
| 2024-12-31 | $131.00K 10-K · filed 2026-03-13 |
| 2024-09-30 | $147.00K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $162.00K 10-Q · filed 2024-08-12 |
| 2024-03-31 | $133.00K 10-Q · filed 2024-05-09 |
| 2023-12-31 | $176.00K 10-K · filed 2025-03-27 |
| 2023-09-30 | $201.00K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $221.00K 10-Q · filed 2023-08-10 |
| 2023-03-31 | $137.00K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $231.00K 10-K · filed 2024-03-07 |
| 2022-09-30 | $240.00K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $260.00K 10-Q · filed 2022-08-11 |
| 2022-03-31 | $187.00K 10-Q · filed 2022-05-11 |
| 2021-12-31 | $427.00K 10-K · filed 2023-03-30 |
| 2021-09-30 | $369.00K 10-Q · filed 2021-11-12 |
| 2021-06-30 | $375.00K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $213.00K 10-Q · filed 2021-05-13 |
| 2020-12-31 | $453.00K 10-K · filed 2022-03-30 |
| 2020-09-30 | $475.00K 10-Q · filed 2020-11-05 |
| 2020-06-30 | $530.00K 10-Q · filed 2020-08-06 |
| 2020-03-31 | $86.00K 10-Q · filed 2020-05-07 |
| 2019-12-31 | $247.00K 10-K · filed 2021-03-10 |
| 2019-09-30 | $74.00K 10-Q · filed 2019-11-07 |
| 2019-06-30 | $261.00K 10-Q · filed 2019-08-08 |
| 2019-03-31 | $121.00K 10-Q · filed 2019-05-09 |
| 2018-12-31 | $162.00K 10-K · filed 2020-03-12 |
| 2018-09-30 | $289.00K 10-Q · filed 2018-11-07 |
| 2018-06-30 | $430.00K 10-Q · filed 2018-08-09 |
| 2018-03-31 | $123.00K 10-Q · filed 2018-05-09 |
| 2017-12-31 | $158.00K 10-K · filed 2019-03-13 |
| 2017-09-30 | $263.00K 10-Q · filed 2017-11-08 |
| 2017-06-30 | $368.00K 10-Q · filed 2017-08-09 |
| 2016-12-31 | $35.00K 10-K · filed 2018-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B |